B. Chevalier

2.1k total citations
64 papers, 1.3k citations indexed

About

B. Chevalier is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, B. Chevalier has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in B. Chevalier's work include Cystic Fibrosis Research Advances (15 papers), Neonatal Respiratory Health Research (9 papers) and Tracheal and airway disorders (7 papers). B. Chevalier is often cited by papers focused on Cystic Fibrosis Research Advances (15 papers), Neonatal Respiratory Health Research (9 papers) and Tracheal and airway disorders (7 papers). B. Chevalier collaborates with scholars based in France, Senegal and Canada. B. Chevalier's co-authors include Pascal Barbry, Brice Marcet, Laurent Kodjabachian, Karine Robbe-Sermesant, Alexandre Hinzpeter, Bruno Cardinaud, Laure‐Emmanuelle Zaragosi, Jean‐François Poulin, Sylvie Laforest and Guy Drolet and has published in prestigious journals such as Nature Communications, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

B. Chevalier

59 papers receiving 1.2k citations

Peers

Countries citing papers authored by B. Chevalier

Since Specialization

Citations

This map shows the geographic impact of B. Chevalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Chevalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Chevalier more than expected).

Fields of papers citing papers by B. Chevalier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Chevalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Chevalier. The network helps show where B. Chevalier may publish in the future.

Co-authorship network of co-authors of B. Chevalier

This figure shows the co-authorship network connecting the top 25 collaborators of B. Chevalier. A scholar is included among the top collaborators of B. Chevalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Chevalier. B. Chevalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells 2024 ·Cell Reports Medicine ·(unknown), (unknown), (unknown), Giulia Maule, Elise Dréano, Mairead Kelly, (unknown), (unknown), (unknown), (unknown), Aurélie Hatton, B. Chevalier, Anabela S. Ramalho, Xavier Casadevall i Solvas, Zeger Debyser, F. Vermeulen, Rik Gijsbers, Isabelle Sermet‐Gaudelus, Anna Cereseto, Marianne Carlon	35
2	Novel gain-of-function mutants identify a critical region within CFTR membrane-spanning domain 2 controlling cAMP-dependent and ATP-independent channel activation 2024 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), B. Chevalier, (unknown), Iwona Pranke, (unknown), Aleksander Edelman, Isabelle Sermet‐Gaudelus, Jean‐Paul Mornon, Isabelle Callebaut, Alexandre Hinzpeter	1
3	Effects of skin-to-skin contact in supported diagonal flexion positioning on movement quality in very preterm infants at term age 2024 ·Early Human Development ·(unknown), (unknown), B. Chevalier, Émmanuel Devouche	0
4	Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium 2023 ·Frontiers in Pharmacology ·(unknown), (unknown), Elise Dréano, B. Chevalier, Aurélie Hatton, Mairead Kelly, (unknown), Gabrielle Planelles, Aleksander Edelman, Emmanuelle Girodon, Alexandre Hinzpeter, Gilles Crambert, Iwona Pranke, Luis J. V. Galietta, Isabelle Sermet‐Gaudelus	2
5	Modulators of CFTR. Updates on clinical development and future directions 2021 ·European Journal of Medicinal Chemistry ·Emmanuelle Bardin, (unknown), Michaëla Semeraro, Anita Golec, (unknown), B. Chevalier, Farouk Berhal, Guillaume Prestat, Alexandre Hinzpeter, Christine Gravier‐Pelletier, Iwona Pranke, Isabelle Sermet‐Gaudelus	44
6	Exon identity influences splicing induced by exonic variants and in silico prediction efficacy 2020 ·Journal of Cystic Fibrosis ·Natacha Martin, Anne Bergougnoux, (unknown), B. Chevalier, (unknown), David Baux, Bruno Costes, Pascale Fanen, Caroline Raynal, Isabelle Sermet‐Gaudelus, Emmanuelle Girodon, Magali Taulan‐Cadars, Alexandre Hinzpeter	6
7	Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activity 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Benjamin Boucherle, Arnaud Billet, (unknown), Brice Hoffmann, (unknown), Renaud Zelli, Waël Zeinyeh, Romain Haudecoeur, B. Chevalier, (unknown), (unknown), Christophe Simard, Pierre Lehn, Jean‐Paul Mornon, Alexandre Hinzpeter, Frédéric Becq, Isabelle Callebaut, Jean‐Luc Décout	9
8	The influence of CFTR complex alleles on precision therapy of cystic fibrosis 2019 ·Journal of Cystic Fibrosis ·B. Chevalier, Alexandre Hinzpeter	27
9	Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons 2018 ·ERJ Open Research ·Iwona Pranke, Laure Bidou, Natacha Martin, Sandra Blanchet, Aurélie Hatton, (unknown), (unknown), Bruno Costes, B. Chevalier, Danielle Tondelier, Emmanuelle Girodon, (unknown), Aleksander Edelman, Pascale Fanen, Olivier Namy, Isabelle Sermet‐Gaudelus, Alexandre Hinzpeter	36
10	Distinct epithelial gene expression phenotypes in childhood respiratory allergy 2011 ·European Respiratory Journal ·Lisa Giovannini‐Chami, Brice Marcet, Chimène Moreilhon, B. Chevalier, (unknown), Kévin Lebrigand, Karine Robbe-Sermesant, T. Bourrier, Jean‐François Michiels, Bernard Mari, Dominique Crénesse, Paul Hofman, J. de Blic, L. Castillo, Marc Albertini, Pascal Barbry	59
11	Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway 2011 ·Nature Cell Biology ·Brice Marcet, B. Chevalier, Guillaume Luxardi, Christelle Coraux, Laure‐Emmanuelle Zaragosi, Marie Cibois, Karine Robbe-Sermesant, T. Jolly, Bruno Cardinaud, Chimène Moreilhon, Lisa Giovannini‐Chami, Béatrice Nawrocki‐Raby, Philippe Birembaut, Rainer Waldmann, Laurent Kodjabachian, Pascal Barbry	230
12	Epidemiological investigation of death cases by pesticide poisoning 2010 ·Adama Tall, Antarou Ly, Pierre Nabeth, Amadou A. Sall, Fatoumata Diène Sarr, Joseph Faye, Aïda Sadikh Badiane, (unknown), R. Michel, (unknown), (unknown), Alexis Bazire, Laurence Marrama, R. Garnier, F Simón, (unknown), B. Chevalier	9
13	Épidémiologie de la résistance de Mycobacterium tuberculosis aux antituberculeux à l’hôpital principal de Dakar. Étude rétrospective sur quatre ans (2000–2003) 2010 ·Revue de Pneumologie Clinique ·B. Chevalier, J. Margery, (unknown), (unknown), Nicolas Lefèbvre, (unknown), (unknown), Jean-David Perrier-Gros-Claude, François Simon, M. Fabre, (unknown), Vincent Hervé, P S Mbaye, (unknown)	3
14	Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions 2009 ·PLoS ONE ·Nicolas Pottier, Thomas Maurin, B. Chevalier, Marie-Pierre Puisségur, Kévin Lebrigand, Karine Robbe-Sermesant, Thomas Bertero, Christian L. Lino Cardenas, Elisabeth Courcot, Géraldine Rios, Sandra Fourré, Jean‐Marc Lo‐Guidice, Brice Marcet, Bruno Cardinaud, Pascal Barbry, Bernard Mari	174
15	Une épaule douloureuse révélant une tuberculose osseuse inhabituelle 2009 ·Revue de Pneumologie Clinique ·(unknown), (unknown), (unknown), Nicolas Lefèbvre, B. Chevalier, (unknown), P.S. Mbaye, J. Margery	1
16	Le traitement antituberculeux présomptif est-il licite dans la pleurésie lymphocytaire exsudative inexpliquée au Sénégal ? 2007 ·Revue de Pneumologie Clinique ·(unknown), (unknown), Nicolas Lefèbvre, (unknown), (unknown), (unknown), (unknown), B. Chevalier, (unknown), (unknown), J. Margery	3
17	Le syndrome de Marfan 2001 ·Florence Tubach, Cathérine Boileau, B. Chevalier, Guillaume Jondeau, J. M. Le Parc, (unknown), (unknown), P. Plantin, (unknown)	9
18	A case matched comparison between three new tubular stents 1998 ·Journal of the American College of Cardiology ·B. Chevalier, B Glatt, (unknown), Thierry Royer	3
19	Insulin-like growth factor-I-stimulated glucose transport in myotubes derived from chicken muscle satellite cells 1993 ·Journal of Endocrinology ·Michel Jacques M.J. Duclos, B. Chevalier, Y. Le Marchand‐Brustel, Jean‐François Tanti, C. Goddard, (unknown)	49
20	Regulation of amino acid transport and protein metabolism in myotubes derived from chicken muscle satellite cells by insulin‐like growth factor‐I 1993 ·Journal of Cellular Physiology ·Michel Jacques M.J. Duclos, B. Chevalier, C. Goddard, (unknown)	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact